Session Details
[O16]Oral Presentation 16
Sun. Sep 27, 2026 10:00 AM - 10:50 AM JST
Sun. Sep 27, 2026 1:00 AM - 1:50 AM UTC
Sun. Sep 27, 2026 1:00 AM - 1:50 AM UTC
Room 6(2F Conference Room 201)
Chair:Minoru Kidokoro, Misako Nakayama
[O16-01]Immunogenicity, Reactogenicity, and Safety of an mRNA-Based Seasonal Influenza and SARS-CoV-2 Multicomponent Vaccine, mRNA-1083, in Adults Aged ≥50 Years in Japan
*Osamu Kogawara1, Hiroyuki Fukase2, Alexander Rumyantsev3, Koichi Hashizume1, Seun Osibajo3, Lusine Kostanyan3 (1. Moderna Japan Co., Ltd., 2. General Incorporated Association, Clinical Research Hospital Tokyo, 3. Moderna, Inc.)
[O16-02]腸管粘膜の長期免疫記憶を誘導する抗原運搬型ヒト肺サーファクタント由来の人工合成粘膜アジュバントSF-10を用いた経口インフルエンザワクチンの機能解析
*Satoko Sakai1, Takashi Kimoto1,2, Etsuhisa Takahashi1, Keiko Kameda1, Hiroshi Kido1 (1. Tokushima Univ., 2. Kobe Gakuin Univ.)
[O16-03]非ヒト霊長類モデルにおける膜融合型HA抗原およびTLR7アゴニストを用いたユニバーサルインフルエンザワクチンの免疫学的評価
*Ayae Nishiyama1, Takuto Nogimori1, Yuji Masuta1, Yu Adachi2, Hidenori Kimura3, Akihisa Fukushima3, Yoshimasa Takahashi2, Takuya Yamamoto1,4,5 (1. National Institutes of Biomedical Innovation, Health and Nutrition, 2. Japan Institute for Health Security, National Institute of Infectious Diseases, 3. Sumitomo Pharma. Co., Ltd., 4. Graduate School of Pharmaceutical Sciences, Osaka Univ., 5. Graduate School of Medicine,Osaka Univ.)
[O16-04]ガス式針なし注入器によるインフルエンザワクチン投与時の抗体価の検討
*Yoshiaki Yamagishi1, Hironori Nakagami2 (1. The University of Osaka Hospital, 2. Graduate School of Medicine, The University of Osaka)
[O16-05]カニクイザル感染防御モデルを用いたおたふくかぜワクチンの新たな接種経路の検討
*Minoru Kidokoro1, Fumihiro Kato1 (1. Japan Institute for Health Security)
